Construction and outcome analysis of cough and asthma pharmaceutical care model involving clinical pharmacists
Objective To explore the establishment of standardized cough and asthma pharmaceutical care outpatient model for patients with chronic airway diseases and evaluate its results.Methods From January 2022 to December 2022,61 patients with chronic obstructive pulmonary disease(COPD)and 139 patients with asthma were selected from the outpatient department of cough and asthma pharmaceutical care in Kunshan First People's Hospital.Standardized outpatient department of cough and asthma pharmaceutical care was set up:Clinical pharmacists establish/update patient files,evaluate patients,provide individualized medication guidance to patients,and follow up patients with different chronic airway diseases in different ways.General data,medication compliance before and after follow-up(MMAS-8)score,inhalation device use score,COPD patient self-assessment test(CAT)questionnaire score,asthma control assessment Test(ACT)questionnaire score were analyzed.Results Among the 61 COPD patients,there were more men than women,and the most patients aged 50 to 69 years old.The number of inhalation devices used were budesonide formoterol powder inhalation,budegforol inhalation aerosol and tiotropium bromide inhalation aerosol in order from most to least.Among 139 patients with asthma,more men than women,and the patients aged 30～49 years were the most.The number of inhaling devices used was budesonide formoterol powder inhaler,budegforol inhalation aerosol and tiotropium bromide inhaler in order from most to least.According to the COPD Global Initiative(GOLD)guidelines,GOLD grade 1～2 COPD patients were followed up 12 months later,the MMAS-8 score and the score of inhalation device use were significantly increased,and the CAT score was significantly decreased,with statistical significance(P＜0.05).The patients with GOLD grade 3～4 COPD were followed up 6 months later,the MMAS-8 score and the score of inhalation device use were significantly increased,and the CAT score was significantly decreased,with statistical significance(P＜0.05).The patients with asthma were followed up 1 month later,and the scores of MMAS-8,inhalation device use and ACT were significantly increased,with statistical significance(P＜0.05).Conclusion Standardized pharmaceutical care mode for cough and asthma can significantly improve the medication compliance of patients,help patients with COPD and asthma correctly use inhalation devices,and improve the control of COPD and asthma.By participating in the cough and asthma pharmaceutical care outpatient clinic,clinical pharmacists can further optimize the diagnosis and treatment level of the cough and asthma pharmaceutical care outpatient clinic in the hospital,and provide a basis for future pharmaceutical care for other chronic diseases.
Pharmaceutical care outpatient clinicClinical pharmacistSuction deviceChronic obstructive pulmonary diseaseAsthma
万方数据
维普
